Olema Pharmaceuticals inc (OLMA)
10.67
+0.60
(+5.96%)
USD |
NASDAQ |
May 03, 16:00
10.66
-0.01
(-0.09%)
After-Hours: 20:00
Olema Pharmaceuticals Market Cap: 596.61M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 596.61M |
| May 02, 2024 | 563.06M |
| May 01, 2024 | 581.51M |
| April 30, 2024 | 568.65M |
| April 29, 2024 | 568.09M |
| April 26, 2024 | 556.35M |
| April 25, 2024 | 549.64M |
| April 24, 2024 | 567.53M |
| April 23, 2024 | 559.15M |
| April 22, 2024 | 551.88M |
| April 19, 2024 | 555.23M |
| April 18, 2024 | 553.56M |
| April 17, 2024 | 598.85M |
| April 16, 2024 | 605.00M |
| April 15, 2024 | 606.67M |
| April 12, 2024 | 607.23M |
| April 11, 2024 | 645.81M |
| April 10, 2024 | 611.71M |
| April 09, 2024 | 644.70M |
| April 08, 2024 | 630.16M |
| April 05, 2024 | 598.29M |
| April 04, 2024 | 587.66M |
| April 03, 2024 | 619.53M |
| April 02, 2024 | 606.12M |
| April 01, 2024 | 608.91M |
| Date | Value |
|---|---|
| March 28, 2024 | 632.95M |
| March 27, 2024 | 626.24M |
| March 26, 2024 | 612.27M |
| March 25, 2024 | 613.38M |
| March 22, 2024 | 627.92M |
| March 21, 2024 | 645.81M |
| March 20, 2024 | 650.29M |
| March 19, 2024 | 645.81M |
| March 18, 2024 | 619.53M |
| March 15, 2024 | 645.81M |
| March 14, 2024 | 646.93M |
| March 13, 2024 | 698.93M |
| March 12, 2024 | 678.80M |
| March 11, 2024 | 726.89M |
| March 08, 2024 | 726.89M |
| March 07, 2024 | 786.72M |
| March 06, 2024 | 786.95M |
| March 05, 2024 | 760.55M |
| March 04, 2024 | 800.70M |
| March 01, 2024 | 813.89M |
| February 29, 2024 | 681.91M |
| February 28, 2024 | 713.26M |
| February 27, 2024 | 754.50M |
| February 26, 2024 | 744.05M |
| February 23, 2024 | 741.85M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
82.32M
Minimum
May 11 2022
2.189B
Maximum
Dec 01 2020
632.72M
Average
425.10M
Median
Market Cap Benchmarks
| Geron Corp | 2.331B |
| Verastem Inc | 275.85M |
| Fate Therapeutics Inc | 402.90M |
| Karyopharm Therapeutics Inc | 130.03M |
| Alpine Immune Sciences Inc | 4.235B |
Market Cap Related Metrics
| Price to Book Value | 2.350 |
| Price | 10.67 |
| Earnings Yield | -20.15% |